Table 5.
Factors associated with help‐seeking for unmet supportive care needs in men with prostate cancer
| Supportive care needs | Any need (n = 272) | Physical and daily living need (n = 134) | Psychological need (n = 156) | Health system and info need (n = 102) | Sexuality need (n = 192) | Prostate cancer‐specific needa (n = 190) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Factors | OR (CI 95%) | P | OR (CI 95%) | P | OR (CI 95%) | P | OR (CI 95%) | P | OR (CI 95%) | P | OR (CI 95%) | P |
| Age (years) | 0.94 (0.89–0.99) | 0.03 | 0.88 (0.80–0.98) | 0.02 | 0.92 (0.85–1.01) | 0.10 | 0.91 (0.83–1.00) | 0.06 | 0.95 (0.88–1.03) | 0.20 | 0.92 (0.86–0.99) | 0.03 |
| Education | ||||||||||||
| University/college | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | ||||||
| Trade/technical | 0.38 (0.13–1.14) | 0.09 | 0.58 (0.11–2.93) | 0.51 | 0.66 (0.15–2.89) | 0.58 | 0.43 (0.07–2.69) | 0.37 | 0.69 (0.17–2.80) | 0.61 | 0.31 (0.08–1.27) | 0.10 |
| High school | 0.25 (0.09–0.74) | 0.01 | 0.67 (0.12–3.74) | 0.65 | 0.68 (0.16–2.84) | 0.59 | 0.28 (0.04–1.73) | 0.17 | 0.24 (0.07–0.90) | 0.03 | 0.32 (0.08–1.28) | 0.11 |
| Primary school | 0.07 (0.02–0.28) | < 0.001 | 0.14 (0.02–0.90) | 0.04 | 0.09 (0.02–0.51) | 0.007 | 0.06 (0.01–0.64) | 0.02 | 0.10 (0.02–0.57) | 0.009 | 0.08 (0.02–0.42) | 0.003 |
| Months since dx | 0.92 (0.76–1.10) | 0.36 | 0.99 (0.74–1.32) | 0.95 | 0.98 (0.75–1.28) | 0.88 | 0.74 (0.53–1.05) | 0.09 | 0.72 (0.53–0.97) | 0.03 | 0.96 (0.77–1.21) | 0.75 |
| ADT | ||||||||||||
| Absence | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | ||||||
| Presence | 0.82 (0.34–2.01) | 0.67 | 0.85 (0.22–3.19) | 0.80 | 0.49 (0.14–1.76) | 0.27 | 0.98 (0.21–4.65) | 0.98 | 0.42 (0.12–1.50) | 0.18 | 0.92 (0.29–2.90) | 0.88 |
| BSI‐18 | ||||||||||||
| Somatisation | 1.11 (0.90–1.36) | 0.32 | 1.23 (0.89–1.70) | 0.20 | 1.08 (0.83–1.42) | 0.56 | 1.35 (0.92–1.97) | 0.12 | 1.04 (0.75–1.44) | 0.81 | 1.17 (0.89–1.54) | 0.25 |
| Depression | 0.83 (0.70–0.98) | 0.03 | 0.93 (0.74–1.17) | 0.51 | 0.71 (0.57–0.87) | 0.001 | 0.77 (0.60–1.00) | 0.05 | 0.81 (0.66–1.00) | 0.05 | 0.83 (0.68–1.00) | 0.05 |
| Anxiety | 1.09 (0.86–1.40) | 0.47 | 0.88 (0.64–1.22) | 0.45 | 1.28 (0.91–1.80) | 0.15 | 1.23 (0.86–1.78) | 0.26 | 1.10 (0.81–1.50) | 0.54 | 1.07 (0.81–1.41) | 0.65 |
| EPIC | ||||||||||||
| Urinary | 1.00 (0.97–1.02) | 0.82 | 1.02 (0.98–1.05) | 0.35 | 1.00 (0.96–1.03) | 0.81 | 1.01 (0.98–1.05) | 0.47 | 0.99 (0.96–1.03) | 0.72 | 1.00 (0.97–1.03) | 0.93 |
| Bowel | 0.97 (0.93–1.02) | 0.20 | 0.99 (0.94–1.04) | 0.65 | 0.98 (0.92–1.03) | 0.39 | 0.99 (0.94–1.06) | 0.93 | 0.93 (0.87–1.00) | 0.06 | 1.00 (0.95–1.04) | 0.79 |
| Sexual | 1.00 (0.98–1.02) | 0.94 | 1.00 (0.97–1.04) | 0.93 | 0.98 (0.96–1.01) | 0.26 | 1.00 (0.96–1.04) | 0.97 | 1.03 (1.00–1.06) | 0.03 | 1.01 (0.98–1.03) | 0.53 |
Ref., Reference; ADT, androgen deprivation therapy; dx, diagnosis.
a
The two items that could be confounded with side effects from androgen deprivation therapy were excluded from this scale for analysis (experiencing hot flushes, and going through a change of life like women do). Bolding in the table denotes a statistically significant result.